Bhatia Robin, Hashemi Parastoo, Razzaq Ashfaq, Parkin Mark C, Hopwood Sarah E, Boutelle Martyn G, Strong Anthony J
Department of Clinical Neurosciences, Kings College London, GKT School of Medicine, Kings Denmark Hill Campus, London, England.
Neurosurgery. 2006 Apr;58(4 Suppl 2):ONS-313-20; discussion ONS-321. doi: 10.1227/01.NEU.0000208963.42378.83.
To introduce rapid-sampling microdialysis for the early detection of adverse metabolic changes in tissue at risk during aneurysm surgery.
A microdialysis catheter was inserted under direct vision into at-risk cortex at the start of surgery. This monitoring was sustained throughout the course of the operation, during which intraoperative events, for example, temporary arterial occlusion or lobe retraction, were precisely documented. A continuous online flow of dialysate was fed into a mobile bedside glucose and lactate analyser. This comprises flow-injection dual-assay enzyme-based biosensors capable of determining values of metabolites every 30 seconds.
Eight patients underwent clipping or wrapping of intracranial aneurysms and were monitored. Time between events and detection: 9 minutes. Mean change in metabolite value +/- standard deviation: temporal lobe retraction lactate, +656 +/- 562 micromol/L (n = 7, P < 0.05); glucose, -123 +/- 138 micromol/L (n = 6, P = 0.08). Glucose intravenous bolus infusion glucose, +512 +/- 244 micromol/L (n = 5, P < 0.01); peak at mean time after bolus, 16 minutes. Temporary proximal clip lactate, +731 +/- 346 micromol/L (n = 6, P < 0.01); glucose, -139 +/- 96 micromol/L (n = 5, P < 0.05); mean clip time, 8.6 minutes.
The technique detects changes 9 minutes after intraoperative events occur (limited only by probe-to-sensor tubing length and dialysate flow rate). This provides reliable information to the surgeon and anesthetist promptly. It is a useful method for monitoring glucose and lactate in dialysate, particularly when rapid, transient changes in brain analyte levels need to be determined and the alternative offline methodology would be inadequate.
介绍快速采样微透析技术用于在动脉瘤手术期间早期检测处于危险状态组织中的不良代谢变化。
在手术开始时,在直视下将微透析导管插入处于危险状态的皮质。在整个手术过程中持续进行这种监测,在此期间精确记录术中事件,例如临时动脉闭塞或脑叶回缩。将连续在线流动的透析液输入便携式床边葡萄糖和乳酸分析仪。该分析仪包括基于流动注射双分析酶的生物传感器,能够每30秒测定一次代谢物的值。
8例患者接受了颅内动脉瘤夹闭或包裹手术并进行了监测。事件与检测之间的时间:9分钟。代谢物值的平均变化±标准差:脑叶回缩时乳酸,+656±562微摩尔/升(n = 7,P < 0.05);葡萄糖,-123±138微摩尔/升(n = 6,P = 0.08)。静脉推注葡萄糖时葡萄糖,+512±244微摩尔/升(n = 5,P < 0.01);推注后平均时间16分钟时达到峰值。临时近端夹闭时乳酸,+731±346微摩尔/升(n = 6,P < 0.01);葡萄糖,-139±96微摩尔/升(n = 5,P < 0.05);平均夹闭时间8.6分钟。
该技术在术中事件发生后9分钟即可检测到变化(仅受探头至传感器管路长度和透析液流速限制)。这能迅速为外科医生和麻醉师提供可靠信息。它是监测透析液中葡萄糖和乳酸的有用方法,特别是当需要确定脑分析物水平的快速、短暂变化且替代的离线方法不适用时。